Islet cell autoantibody levels after the diagnosis of young adult diabetic patients

Aims  The aim was to determine the course of islet cell antibodies [glutamate decarboxylase (GADA), tyrosine phosphatase‐like islet antigen 2 (IA‐2A) and islet cell (ICA)] after the diagnosis of the diabetic patient.

[1]  L. Nyström,et al.  Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15-34 years. , 2009, Acta medica Scandinavica.

[2]  N. Breslow,et al.  Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects. , 2007, Journal of diabetes and its complications.

[3]  M. Araie,et al.  Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy. , 2005, Ophthalmology.

[4]  Ronnie Driver,et al.  Biostatistics: a Methodology for the Health Sciences , 2005 .

[5]  Å. Lernmark,et al.  A high prevalence of organ-specific autoimmunity in patients with bipolar disorder , 2004, Biological Psychiatry.

[6]  M. Dalakas,et al.  Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. , 2004, Archives of neurology.

[7]  L. Nyström,et al.  Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in Sweden , 2004, Journal of internal medicine.

[8]  P. Bingley,et al.  Diabetes Antibody Standardization Program: first assay proficiency evaluation. , 2003, Diabetes.

[9]  P. Fernlund,et al.  A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. , 2002, Diabetes.

[10]  N. Breslow,et al.  Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. , 2002, Diabetes.

[11]  M. Landin-Olsson,et al.  Predictability of C‐peptide for autoimmune diabetes in young adult diabetic patients , 2001 .

[12]  Å. Lernmark,et al.  Combinations of Beta Cell Specific Autoantibodies at Diagnosis of Diabetes in Young Adults Reflects Different Courses of Beta Cell Damage , 2001, Autoimmunity.

[13]  Å. Lernmark,et al.  Prognostic Factors for the Course of β Cell Function in Autoimmune Diabetes , 2000 .

[14]  Jan Eriksson,et al.  Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds , 2000, Diabetes/metabolism research and reviews.

[15]  Å. Lernmark,et al.  Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  Å. Lernmark,et al.  Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus – a nationwide study , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[17]  P. Fernlund,et al.  Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes , 2000, Acta paediatrica.

[18]  M. Knip,et al.  Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. , 1999, The Journal of clinical endocrinology and metabolism.

[19]  Å. Lernmark,et al.  Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. , 1999, Diabetes care.

[20]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[21]  P. Bingley,et al.  Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.

[22]  Å. Lernmark,et al.  A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes , 1998 .

[23]  Å. Lernmark,et al.  Inverse relationship between GAD65 antibody levels and severe retinopathy in younger type 1 diabetic patients. , 1998, Diabetes research and clinical practice.

[24]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[25]  Roberto Gianani,et al.  ICA512 Autoantibody Radioassay , 1995, Diabetes.

[26]  Å. Lernmark,et al.  Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. , 1995, Journal of immunological methods.

[27]  M. Christie,et al.  Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). , 1995, The Journal of clinical investigation.

[28]  Å. Lernmark,et al.  Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes. , 1995, Diabetes research and clinical practice.

[29]  M. Lan,et al.  Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. , 1994, DNA and cell biology.

[30]  M. Rowley,et al.  Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[31]  D. Goldstein,et al.  Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. , 1994, Journal of immunology.

[32]  L. Nyström,et al.  Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children , 1992, Diabetologia.

[33]  O. Madsen,et al.  Recombinant Glutamic Acid Decarboxylase (Representing the Single Isoform Expressed in Human Islets) Detects IDDM-Associated 64,000-Mr Autoantibodies , 1992, Diabetes.

[34]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[35]  D. Adler,et al.  Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[37]  Å. Lernmark,et al.  Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus , 1990, Diabetologia.

[38]  Å. Lernmark,et al.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus , 1987, Diabetologia.

[39]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[40]  J. Palmer,et al.  Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.

[41]  Å. Lernmark,et al.  Islet-cell-surface antibodies in juvenile diabetes mellitus. , 1978, The New England journal of medicine.

[42]  E. Barnes,et al.  Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. , 1974, Lancet.

[43]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[44]  Graham-Stewart Cw.  TERMINATION OF PREGNANCY ON PSYCHIATRIC GROUNDS. , 1964 .

[45]  P. Bingley,et al.  Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization program. , 2002, Diabetes technology & therapeutics.

[46]  Å. Lernmark,et al.  Prognostic factors for the course of beta cell function in autoimmune diabetes. , 2000, The Journal of clinical endocrinology and metabolism.

[47]  Å. Lernmark,et al.  A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). , 1998, Journal of immunological methods.

[48]  O. Olerup,et al.  DR "low-resolution" PCR-SSP typing--a correction and an up-date. , 1993, Tissue antigens.